Combination Cancer Therapy Using Chimeric Antigen Receptor-Engineered Natural Killer Cells as Drug Carriers
2017 · Molecular Therapy · 101 citations
https://doi.org/10.1016/j.ymthe.2017.08.010
P
Pin Wang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
213
Papers
7.9K
Citations
48
h-index
110
i10-index
Pin Wang is an academic researcher from University of Southern California. The author has contributed to research in topics: CAR-T cell therapy research & Virus-based gene therapy research & Immunotherapy and Immune Responses. The author has an h-index of 48, co-authored 182 publications.
ORCID: 0000-0002-4132-105XPapers by this author
worksGeneration of allogeneic CAR-NKT cells from hematopoietic stem and progenitor cells using a clinically guided culture method
2024 · Nature Biotechnology · 76 citations
https://doi.org/10.1038/s41587-024-02226-y
Serum Stable Natural Peptides Designed by mRNA Display
2014 · Scientific Reports · 61 citations
https://doi.org/10.1038/srep06008
A multi-antigen vaccine in combination with an immunotoxin targeting tumor-associated fibroblast for treating murine melanoma
2016 · Molecular Therapy — Oncolytics · 39 citations
https://doi.org/10.1038/mto.2016.7
ERK Activation in CAR T Cells Is Amplified by CD28-Mediated Increase in CD3ζ Phosphorylation
2020 · iScience · 36 citations
https://doi.org/10.1016/j.isci.2020.101023
Engineering fusogenic molecules to achieve targeted transduction of enveloped lentiviral vectors
2009 · Journal of Biological Engineering · 33 citations
https://doi.org/10.1186/1754-1611-3-8
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat